133 related articles for article (PubMed ID: 38366390)
1. Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults.
Croop R; Bhardwaj R; Anderson MS; Matschke KT; Hould J; Bertz R; Liu J; Lipton RB
Cephalalgia; 2024 Feb; 44(2):3331024231219505. PubMed ID: 38366390
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.
Croop R; Goadsby PJ; Stock DA; Conway CM; Forshaw M; Stock EG; Coric V; Lipton RB
Lancet; 2019 Aug; 394(10200):737-745. PubMed ID: 31311674
[TBL] [Abstract][Full Text] [Related]
3. Rimegepant Orally Disintegrating Tablet for Acute Migraine Treatment: A Review.
DeFalco AP; Lazim R; Cope NE
Ann Pharmacother; 2021 May; 55(5):650-657. PubMed ID: 32909437
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence of Esaxerenone Conventional Tablet and Orally Disintegrating Tablet: Two Single-Dose Crossover Studies in Healthy Japanese Men.
Kurata A; Eto T; Tsutsumi J; Igawa Y; Nishikawa Y; Ishizuka H
Clin Pharmacol Drug Dev; 2022 Aug; 11(8):957-965. PubMed ID: 35315257
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a novel orodispersible tablet of sildenafil in healthy subjects.
Damle B; Duczynski G; Jeffers BW; Crownover P; Coupe A; LaBadie RR
Clin Ther; 2014 Feb; 36(2):236-44. PubMed ID: 24447534
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Bioequivalence of 2 Olanzapine Orally Disintegrating Tablet Products in Healthy Chinese Subjects Under Fed and Fasting Conditions.
Fan L; Zhang L; Zheng H; Cheng J; Hu Y; Liu J; Fan H
Clin Pharmacol Drug Dev; 2020 Jul; 9(5):593-601. PubMed ID: 32413238
[TBL] [Abstract][Full Text] [Related]
8. Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial.
Yu S; Guo A; Wang Z; Liu J; Tan G; Yang Q; Zhang M; Yibulaiyin H; Chen H; Zhang Y; Croop R; Sun Y; Liu Y; Zhao Q; Lu Z
J Headache Pain; 2024 Apr; 25(1):57. PubMed ID: 38627638
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male volunteers.
Liu YM; Liu GY; Liu Y; Li SJ; Jia JY; Zhang MQ; Lu C; Zhang YM; Li XN; Yu C
Clin Ther; 2009 Aug; 31(8):1787-95. PubMed ID: 19808137
[TBL] [Abstract][Full Text] [Related]
10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
Nakade S; Komaba J; Ohno T; Kitagawa J; Furukawa K; Miyata Y
Int J Clin Pharmacol Ther; 2008 Jan; 46(1):42-7. PubMed ID: 18218297
[TBL] [Abstract][Full Text] [Related]
12. A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
Stark JG; Engelking D; McMahen R; Sikes C
Postgrad Med; 2016 Sep; 128(7):648-55. PubMed ID: 27488574
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic comparison of orally-disintegrating metoclopramide with conventional metoclopramide tablet formulation in healthy volunteers.
Fass R; Pieniaszek HJ; Thompson JR
Aliment Pharmacol Ther; 2009 Aug; 30(3):301-6. PubMed ID: 19459829
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence and Bioavailability of an Orodispersible Tablet of Sildenafil Citrate in Healthy Chinese Male Subjects.
Lv Y; Luo BY; LaBadie RR; Zhu H; Feng Y; Ernst C; Crownover PH; Liang Y; Zhao Q
Clin Pharmacol Drug Dev; 2020 Jul; 9(5):573-581. PubMed ID: 32463593
[TBL] [Abstract][Full Text] [Related]
15. Rimegepant: First Approval.
Scott LJ
Drugs; 2020 May; 80(7):741-746. PubMed ID: 32270407
[TBL] [Abstract][Full Text] [Related]
16. Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine.
Blair HA
CNS Drugs; 2023 Mar; 37(3):255-265. PubMed ID: 36739335
[TBL] [Abstract][Full Text] [Related]
17. A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV-0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers.
Qureshi I; Lovegren M; Wirtz V; Larouche R; Tanguay M; Anderson MS; Hartmann S; Coric V; Berman RM
Clin Pharmacol Drug Dev; 2020 May; 9(4):476-485. PubMed ID: 31610101
[TBL] [Abstract][Full Text] [Related]
18. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects.
Disanto AR; Golden G
Clin Drug Investig; 2009; 29(8):539-49. PubMed ID: 19591515
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Safety of Single and Multiple Daily Dosing of 75-mg Rimegepant Orally Disintegrating Tablets in Healthy Chinese Adults: A Randomized Placebo-Controlled Trial.
Li Y; Wang X; Ballesteros-Perez A; Bertz R; Lu Z
Clin Pharmacol Drug Dev; 2023 Jun; 12(6):594-601. PubMed ID: 36808268
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence of ondansetron oral soluble film 8 mg (ZUPLENZ) and ondansetron orally disintegrating tablets 8 mg (ZOFRAN) in healthy adults.
Dadey E
Am J Ther; 2015; 22(2):90-7. PubMed ID: 25581856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
